Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.03
J. Woroń
{"title":"Efficacy and safety of using non-steroidal anti-inflammatory drugs in ophthalmology","authors":"J. Woroń","doi":"10.24292/01.OT.300619.03","DOIUrl":"https://doi.org/10.24292/01.OT.300619.03","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130978269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.10
Magdalena Derebecka, A. Grzybowski
1 Wojewódzki Szpital Zespolony w Elblągu, Oddział Okulistyczny Ordynator Oddziału: lek. Janusz Adamski 2 Katedra Okulistyki, Uniwersytet Warmińsko-Mazurski w Olsztynie Kierownik: prof. dr hab. n. med. Andrzej Grzybowski 3 Instytut Okulistycznych Badań Naukowych w Poznaniu Kierownik: prof. dr hab. n. med. Andrzej Grzybowski Rehabilitation of visually impaired children – methods and their effectiveness
{"title":"Rehabilitation of visually impaired children – methods and their effectiveness","authors":"Magdalena Derebecka, A. Grzybowski","doi":"10.24292/01.OT.300619.10","DOIUrl":"https://doi.org/10.24292/01.OT.300619.10","url":null,"abstract":"1 Wojewódzki Szpital Zespolony w Elblągu, Oddział Okulistyczny Ordynator Oddziału: lek. Janusz Adamski 2 Katedra Okulistyki, Uniwersytet Warmińsko-Mazurski w Olsztynie Kierownik: prof. dr hab. n. med. Andrzej Grzybowski 3 Instytut Okulistycznych Badań Naukowych w Poznaniu Kierownik: prof. dr hab. n. med. Andrzej Grzybowski Rehabilitation of visually impaired children – methods and their effectiveness","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121308112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.07
K. Michalska-Małecka, Dorota Śpiewak
H i g H l i g H t s The aim of the study was to analyze the efficacy and safety of dexamethasone intravitreal implant and the anti-VEGF therapy in retinal vein occlusion (RVO) in terms of improving the functional and morphological parameters of the retina and to discuss the individualization of optimal therapy. Czy terapia implantem doszklistkowym deksametazonu jest lepszym wyborem niż iniekcje leków anty-VEGF w leczeniu powikłań zakrzepu naczyń żylnych siatkówki?
本研究的目的是分析地塞米松玻璃体内植入和抗vegf治疗视网膜静脉闭塞(RVO)在改善视网膜功能和形态参数方面的疗效和安全性，并探讨最佳治疗方案的个体化。zzy畸形植入物doszklistkowym deksametazonu jest lepszym wyborem nizyiniekcje leków anti - vegf w leczeniu powikłań zakrzepu naczyzye żylnych siatkówki?
{"title":"Is intravitreal dexamethasone implant a better choice than anti-VEGF therapy to treat complications of RVO in the retina?","authors":"K. Michalska-Małecka, Dorota Śpiewak","doi":"10.24292/01.OT.300619.07","DOIUrl":"https://doi.org/10.24292/01.OT.300619.07","url":null,"abstract":"H i g H l i g H t s The aim of the study was to analyze the efficacy and safety of dexamethasone intravitreal implant and the anti-VEGF therapy in retinal vein occlusion (RVO) in terms of improving the functional and morphological parameters of the retina and to discuss the individualization of optimal therapy. Czy terapia implantem doszklistkowym deksametazonu jest lepszym wyborem niż iniekcje leków anty-VEGF w leczeniu powikłań zakrzepu naczyń żylnych siatkówki?","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115982334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.06
J. Woroń
{"title":"Nepafenac in the practice of an ophthalmologist – what determines its effectiveness and safety of use?","authors":"J. Woroń","doi":"10.24292/01.OT.300319.06","DOIUrl":"https://doi.org/10.24292/01.OT.300319.06","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124707248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.05
A. Hommer
Original drugs and generic drugs used in glaucoma differ from each other. This can lead to worse drug tolerability and, as a result, to worse patients’ compliance. Therefore, an essential issue is, besides the drug’s efficacy, its optimal tolerability for the patient. The potential differences in viscosity, pH, drop size, and surface tension has a potential strong influence on the complex delivery mechanism of the active molecule to the receptors in the eye and its clinical relevant efficacy. These differences, in addition to different appearance and handling of a “new” bottle, may pose problems with patients’ compliance after using a new preparation.
{"title":"Glaucoma and generics in Europe","authors":"A. Hommer","doi":"10.24292/01.OT.300319.05","DOIUrl":"https://doi.org/10.24292/01.OT.300319.05","url":null,"abstract":"Original drugs and generic drugs used in glaucoma differ from each other. This can lead to worse drug tolerability and, as a result, to worse patients’ compliance. Therefore, an essential issue is, besides the drug’s efficacy, its optimal tolerability for the patient. The potential differences in viscosity, pH, drop size, and surface tension has a potential strong influence on the complex delivery mechanism of the active molecule to the receptors in the eye and its clinical relevant efficacy. These differences, in addition to different appearance and handling of a “new” bottle, may pose problems with patients’ compliance after using a new preparation.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132448381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.08
Tomasz Osiej
{"title":"Personal data protection – where to start?","authors":"Tomasz Osiej","doi":"10.24292/01.OT.300319.08","DOIUrl":"https://doi.org/10.24292/01.OT.300319.08","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126270654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.07
M. Schinwelski
{"title":"Blepharospasm – from diagnosis to proper treatment","authors":"M. Schinwelski","doi":"10.24292/01.OT.300319.07","DOIUrl":"https://doi.org/10.24292/01.OT.300319.07","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121926466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.01
J. Czajkowski, R. Grabowski
{"title":"Eye protection against effects of smog","authors":"J. Czajkowski, R. Grabowski","doi":"10.24292/01.OT.300319.01","DOIUrl":"https://doi.org/10.24292/01.OT.300319.01","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123112766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-30DOI: 10.24292/01.OT.300319.02
R. Brygoła
{"title":"Health and safety in relation to vision protection at workplace","authors":"R. Brygoła","doi":"10.24292/01.OT.300319.02","DOIUrl":"https://doi.org/10.24292/01.OT.300319.02","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125207084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：